Intellia Therapeutics

NTLA

Market cap $1.76B

Upgrade to unlock

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$28

85% upside

High target

8 analyst ratings

positive

2 neutral

25%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Jones Trading Debanjana Chatterjee 0% 1-yr NTLA win rate				4 Mar ‘26 1 month ago
Canaccord Genuity Whitney Ijem 50% 1-yr NTLA win rate				3 Mar ‘26 1 month ago
Leerink Partners Mani Foroohar 0% 1-yr NTLA win rate				3 Mar ‘26 1 month ago
RBC Capital Luca Issi 100% 1-yr NTLA win rate				3 Mar ‘26 1 month ago
Wells Fargo Yanan Zhu 100% 1-yr NTLA win rate				3 Mar ‘26 1 month ago
Citizens Silvan Turkcan 0% 1-yr NTLA win rate				3 Mar ‘26 1 month ago
HC Wainwright & Co Mitchell Kapoor 60% 1-yr NTLA win rate				3 Mar ‘26 1 month ago
Chardan Capital Geulah Livshits 50% 1-yr NTLA win rate				2 Mar ‘26 1 month ago